Brain Tumors.
McFaline-Figueroa JR, Lee EQ.
Am J Med. 2018 Aug;131(8):874-882. doi: 10.1016/j.amjmed.2017.12.039. Epub 2018 Jan 31.
Brain tumor rehabilitation.
Vargo M.
Am J Phys Med Rehabil. 2011 May;90(5 Suppl 1):S50-62. doi: 10.1097/PHM.0b013e31820be31f.
Trends in Malignant and Benign Brain Tumor Incidence and Mobile Phone Use in the U.S. (2000-2021): A SEER-Based Study.
Zhang L, Muscat JE.
Int J Environ Res Public Health. 2025 Jun 13;22(6):933. doi: 10.3390/ijerph22060933.
Interdisciplinary Approaches to Survivorship with a Focus on the Low-grade and Benign Brain Tumor Populations.
Worrell SL, Kirschner ML, Shatz RS, Sengupta S, Erickson MG.
Curr Oncol Rep. 2021 Jan 20;23(2):19. doi: 10.1007/s11912-020-01004-8.
Extra-axial brain tumors.
Rapalino O, Smirniotopoulos JG.
Handb Clin Neurol. 2016;135:275-291. doi: 10.1016/B978-0-444-53485-9.00015-5.
[Brain tumor surgery in adults.].
Bagó GA, Nagy GD.
Magy Onkol. 2024 Mar 14;68(1):13-25. Epub 2023 Nov 12.
Efficient brain tumor grade classification using ensemble deep learning models.
M S, Bv B, D P, S AK, Mathivanan SK, Shah MA.
BMC Med Imaging. 2024 Nov 1;24(1):297. doi: 10.1186/s12880-024-01476-1.
Increased time to surgery and worse perioperative outcome in benign brain tumor patients with COVID-19.
Liu KQ, Dallas J, Wenger TA, Ristianto Z, Ding L, Chow F, Zada G, Mack WJ, Attenello FJ.
J Clin Neurosci. 2023 Nov;117:20-26. doi: 10.1016/j.jocn.2023.09.010. Epub 2023 Sep 21.
Geographical variation in malignant and benign/borderline brain and CNS tumor incidence: a comparison between a high-income and a middle-income country.
Wanner M, Rohrmann S, Korol D, Shenglia N, Gigineishvili T, Gigineishvili D.
J Neurooncol. 2020 Sep;149(2):273-282. doi: 10.1007/s11060-020-03595-5. Epub 2020 Aug 19.
Use of Progestogen Tied to Higher Chance of Benign Brain Tumor.
Harris E.
JAMA. 2024 May 14;331(18):1525-1526. doi: 10.1001/jama.2024.5923.
